McKesson
MCK
#242
Rank
NZ$158.85 B
Marketcap
NZ$1,322
Share price
2.02%
Change (1 day)
7.34%
Change (1 year)
McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools.

EPS for McKesson (MCK)

EPS in 2025 (TTM): NZ$60.12

According to McKesson's latest financial reports the company's current EPS (TTM) is NZ$59.47. an increase over its 2024 EPS that were of NZ$37.40.

EPS history for McKesson from 2014 to 2025

Annual EPS

Year EPS Change
2025NZ$59.2258.33%
2024NZ$37.40-1.17%
2023NZ$37.841%
2022NZ$37.47144.72%
2021NZ$15.31-133.49%
2020NZ-$45.71451.13%
2019NZ-$8.29266.17%
2018NZ-$2.27-105.85%
2017NZ$38.73166.28%
2016NZ$14.540.71%
2015NZ$14.4414.44%
2014NZ$12.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Cerner
CERN
NZ$3.41-94.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Henry Schein
HSIC
NZ$5.69-90.44%๐Ÿ‡บ๐Ÿ‡ธ USA
AmerisourceBergen
ABC
NZ$14.12-76.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
NZ$11.19-81.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Premier
PINC
NZ-$0.46-100.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Patterson Companies
PDCO
NZ$2.66-95.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Computer Programs and Systems
CPSI
NZ-$5.36-109.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Veradigm
MDRX
NZ$0.85-98.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Owens & Minor
OMI
NZ-$29.64-149.84%๐Ÿ‡บ๐Ÿ‡ธ USA